ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Prostate Cancer Therapeutics Drugs Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-39D13897
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Prostate Cancer Therapeutics Drugs Market Research Report 2023
BUY CHAPTERS

Global Prostate Cancer Therapeutics Drugs Market Research Report 2025

Code: QYRE-Auto-39D13897
Report
August 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Johnson & Johnson
Pfizer Inc
Astrazeneca plc
Amgen Inc
AbbVie
Bayer
Ipsen Group
Sanofi
Dendreon Corporation
Endo Pharmaceuticals
Johnson & Johnson

Prostate Cancer Therapeutics Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Prostate Cancer Therapeutics Drugs Market

Prostate Cancer Therapeutics Drugs Market

The global market for Prostate Cancer Therapeutics Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Therapeutics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Therapeutics Drugs.
The Prostate Cancer Therapeutics Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prostate Cancer Therapeutics Drugs market comprehensively. Regional market sizes, concerning products by Type, by Sale Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostate Cancer Therapeutics Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Sale Channel, and by regions.

Scope of Prostate Cancer Therapeutics Drugs Market Report

Report Metric Details
Report Name Prostate Cancer Therapeutics Drugs Market
CAGR 5%
Segment by Type
Segment by Sale Channel
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Johnson & Johnson, Pfizer, Inc, AstraZeneca, Amgen, Inc, AbbVie, Inc, Bayer AG, Ipsen Group, Sanofi, Endo Pharmaceuticals, Dendreon Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Prostate Cancer Therapeutics Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Prostate Cancer Therapeutics Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Sale Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Prostate Cancer Therapeutics Drugs Market report?

Ans: The main players in the Prostate Cancer Therapeutics Drugs Market are Johnson & Johnson, Pfizer, Inc, AstraZeneca, Amgen, Inc, AbbVie, Inc, Bayer AG, Ipsen Group, Sanofi, Endo Pharmaceuticals, Dendreon Corporation

What are the Type segmentation covered in the Prostate Cancer Therapeutics Drugs Market report?

Ans: The Types covered in the Prostate Cancer Therapeutics Drugs Market report are Hormone Therapy, Chemotherapy, Biologic Therapy, Targeted Therapy, Other

Recommended Reports

Cancer Drug Markets

Cancer Therapy Innovations

Cancer Market Segments

1 Prostate Cancer Therapeutics Drugs Market Overview
1.1 Product Definition
1.2 Prostate Cancer Therapeutics Drugs by Type
1.2.1 Global Prostate Cancer Therapeutics Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Hormone Therapy
1.2.3 Chemotherapy
1.2.4 Biologic Therapy
1.2.5 Targeted Therapy
1.2.6 Other
1.3 Prostate Cancer Therapeutics Drugs by Sale Channel
1.3.1 Global Prostate Cancer Therapeutics Drugs Market Value by Sale Channel (2024 VS 2031)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Sales
1.3.5 Other
1.4 Global Prostate Cancer Therapeutics Drugs Market Size Estimates and Forecasts
1.4.1 Global Prostate Cancer Therapeutics Drugs Revenue 2020-2031
1.4.2 Global Prostate Cancer Therapeutics Drugs Sales 2020-2031
1.4.3 Global Prostate Cancer Therapeutics Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Prostate Cancer Therapeutics Drugs Market Competition by Manufacturers
2.1 Global Prostate Cancer Therapeutics Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Prostate Cancer Therapeutics Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Prostate Cancer Therapeutics Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Prostate Cancer Therapeutics Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prostate Cancer Therapeutics Drugs, Product Type & Application
2.7 Global Key Manufacturers of Prostate Cancer Therapeutics Drugs, Date of Enter into This Industry
2.8 Global Prostate Cancer Therapeutics Drugs Market Competitive Situation and Trends
2.8.1 Global Prostate Cancer Therapeutics Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Prostate Cancer Therapeutics Drugs Players Market Share by Revenue
2.8.3 Global Prostate Cancer Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Prostate Cancer Therapeutics Drugs Market Scenario by Region
3.1 Global Prostate Cancer Therapeutics Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Prostate Cancer Therapeutics Drugs Sales by Region: 2020-2031
3.2.1 Global Prostate Cancer Therapeutics Drugs Sales by Region: 2020-2025
3.2.2 Global Prostate Cancer Therapeutics Drugs Sales by Region: 2026-2031
3.3 Global Prostate Cancer Therapeutics Drugs Revenue by Region: 2020-2031
3.3.1 Global Prostate Cancer Therapeutics Drugs Revenue by Region: 2020-2025
3.3.2 Global Prostate Cancer Therapeutics Drugs Revenue by Region: 2026-2031
3.4 North America Prostate Cancer Therapeutics Drugs Market Facts & Figures by Country
3.4.1 North America Prostate Cancer Therapeutics Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Prostate Cancer Therapeutics Drugs Sales by Country (2020-2031)
3.4.3 North America Prostate Cancer Therapeutics Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Prostate Cancer Therapeutics Drugs Market Facts & Figures by Country
3.5.1 Europe Prostate Cancer Therapeutics Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Prostate Cancer Therapeutics Drugs Sales by Country (2020-2031)
3.5.3 Europe Prostate Cancer Therapeutics Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prostate Cancer Therapeutics Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Prostate Cancer Therapeutics Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Prostate Cancer Therapeutics Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Prostate Cancer Therapeutics Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Prostate Cancer Therapeutics Drugs Market Facts & Figures by Country
3.7.1 Latin America Prostate Cancer Therapeutics Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Prostate Cancer Therapeutics Drugs Sales by Country (2020-2031)
3.7.3 Latin America Prostate Cancer Therapeutics Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prostate Cancer Therapeutics Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Prostate Cancer Therapeutics Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Prostate Cancer Therapeutics Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Prostate Cancer Therapeutics Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Prostate Cancer Therapeutics Drugs Sales by Type (2020-2031)
4.1.1 Global Prostate Cancer Therapeutics Drugs Sales by Type (2020-2025)
4.1.2 Global Prostate Cancer Therapeutics Drugs Sales by Type (2026-2031)
4.1.3 Global Prostate Cancer Therapeutics Drugs Sales Market Share by Type (2020-2031)
4.2 Global Prostate Cancer Therapeutics Drugs Revenue by Type (2020-2031)
4.2.1 Global Prostate Cancer Therapeutics Drugs Revenue by Type (2020-2025)
4.2.2 Global Prostate Cancer Therapeutics Drugs Revenue by Type (2026-2031)
4.2.3 Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Prostate Cancer Therapeutics Drugs Price by Type (2020-2031)
5 Segment by Sale Channel
5.1 Global Prostate Cancer Therapeutics Drugs Sales by Sale Channel (2020-2031)
5.1.1 Global Prostate Cancer Therapeutics Drugs Sales by Sale Channel (2020-2025)
5.1.2 Global Prostate Cancer Therapeutics Drugs Sales by Sale Channel (2026-2031)
5.1.3 Global Prostate Cancer Therapeutics Drugs Sales Market Share by Sale Channel (2020-2031)
5.2 Global Prostate Cancer Therapeutics Drugs Revenue by Sale Channel (2020-2031)
5.2.1 Global Prostate Cancer Therapeutics Drugs Revenue by Sale Channel (2020-2025)
5.2.2 Global Prostate Cancer Therapeutics Drugs Revenue by Sale Channel (2026-2031)
5.2.3 Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Sale Channel (2020-2031)
5.3 Global Prostate Cancer Therapeutics Drugs Price by Sale Channel (2020-2031)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Company Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Johnson & Johnson Prostate Cancer Therapeutics Drugs Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Pfizer, Inc
6.2.1 Pfizer, Inc Company Information
6.2.2 Pfizer, Inc Description and Business Overview
6.2.3 Pfizer, Inc Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer, Inc Prostate Cancer Therapeutics Drugs Product Portfolio
6.2.5 Pfizer, Inc Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Company Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 AstraZeneca Prostate Cancer Therapeutics Drugs Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Amgen, Inc
6.4.1 Amgen, Inc Company Information
6.4.2 Amgen, Inc Description and Business Overview
6.4.3 Amgen, Inc Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Amgen, Inc Prostate Cancer Therapeutics Drugs Product Portfolio
6.4.5 Amgen, Inc Recent Developments/Updates
6.5 AbbVie, Inc
6.5.1 AbbVie, Inc Company Information
6.5.2 AbbVie, Inc Description and Business Overview
6.5.3 AbbVie, Inc Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 AbbVie, Inc Prostate Cancer Therapeutics Drugs Product Portfolio
6.5.5 AbbVie, Inc Recent Developments/Updates
6.6 Bayer AG
6.6.1 Bayer AG Company Information
6.6.2 Bayer AG Description and Business Overview
6.6.3 Bayer AG Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bayer AG Prostate Cancer Therapeutics Drugs Product Portfolio
6.6.5 Bayer AG Recent Developments/Updates
6.7 Ipsen Group
6.7.1 Ipsen Group Company Information
6.7.2 Ipsen Group Description and Business Overview
6.7.3 Ipsen Group Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Ipsen Group Prostate Cancer Therapeutics Drugs Product Portfolio
6.7.5 Ipsen Group Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Company Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sanofi Prostate Cancer Therapeutics Drugs Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Endo Pharmaceuticals
6.9.1 Endo Pharmaceuticals Company Information
6.9.2 Endo Pharmaceuticals Description and Business Overview
6.9.3 Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Product Portfolio
6.9.5 Endo Pharmaceuticals Recent Developments/Updates
6.10 Dendreon Corporation
6.10.1 Dendreon Corporation Company Information
6.10.2 Dendreon Corporation Description and Business Overview
6.10.3 Dendreon Corporation Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Dendreon Corporation Prostate Cancer Therapeutics Drugs Product Portfolio
6.10.5 Dendreon Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prostate Cancer Therapeutics Drugs Industry Chain Analysis
7.2 Prostate Cancer Therapeutics Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prostate Cancer Therapeutics Drugs Production Mode & Process Analysis
7.4 Prostate Cancer Therapeutics Drugs Sales and Marketing
7.4.1 Prostate Cancer Therapeutics Drugs Sales Channels
7.4.2 Prostate Cancer Therapeutics Drugs Distributors
7.5 Prostate Cancer Therapeutics Drugs Customer Analysis
8 Prostate Cancer Therapeutics Drugs Market Dynamics
8.1 Prostate Cancer Therapeutics Drugs Industry Trends
8.2 Prostate Cancer Therapeutics Drugs Market Drivers
8.3 Prostate Cancer Therapeutics Drugs Market Challenges
8.4 Prostate Cancer Therapeutics Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Johnson & Johnson
Pfizer Inc
Astrazeneca plc
Amgen Inc
AbbVie
Bayer
Ipsen Group
Sanofi
Dendreon Corporation
Endo Pharmaceuticals
Johnson & Johnson
List of Tables
 Table 1. Global Prostate Cancer Therapeutics Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Prostate Cancer Therapeutics Drugs Market Value by Sale Channel (2024 VS 2031) & (US$ Million)
 Table 3. Global Prostate Cancer Therapeutics Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Prostate Cancer Therapeutics Drugs Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Prostate Cancer Therapeutics Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Prostate Cancer Therapeutics Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Prostate Cancer Therapeutics Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Prostate Cancer Therapeutics Drugs Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Prostate Cancer Therapeutics Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Prostate Cancer Therapeutics Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Prostate Cancer Therapeutics Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Prostate Cancer Therapeutics Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Prostate Cancer Therapeutics Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Therapeutics Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Prostate Cancer Therapeutics Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Prostate Cancer Therapeutics Drugs Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Prostate Cancer Therapeutics Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Prostate Cancer Therapeutics Drugs Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Prostate Cancer Therapeutics Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Prostate Cancer Therapeutics Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Prostate Cancer Therapeutics Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Prostate Cancer Therapeutics Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Prostate Cancer Therapeutics Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Prostate Cancer Therapeutics Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Prostate Cancer Therapeutics Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Prostate Cancer Therapeutics Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Prostate Cancer Therapeutics Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Prostate Cancer Therapeutics Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Prostate Cancer Therapeutics Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Prostate Cancer Therapeutics Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Prostate Cancer Therapeutics Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Prostate Cancer Therapeutics Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Prostate Cancer Therapeutics Drugs Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Prostate Cancer Therapeutics Drugs Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Prostate Cancer Therapeutics Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Prostate Cancer Therapeutics Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Prostate Cancer Therapeutics Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Prostate Cancer Therapeutics Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Prostate Cancer Therapeutics Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Prostate Cancer Therapeutics Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Prostate Cancer Therapeutics Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Prostate Cancer Therapeutics Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Prostate Cancer Therapeutics Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Prostate Cancer Therapeutics Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Prostate Cancer Therapeutics Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Prostate Cancer Therapeutics Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Prostate Cancer Therapeutics Drugs Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Prostate Cancer Therapeutics Drugs Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Prostate Cancer Therapeutics Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Prostate Cancer Therapeutics Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Prostate Cancer Therapeutics Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Prostate Cancer Therapeutics Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Prostate Cancer Therapeutics Drugs Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Prostate Cancer Therapeutics Drugs Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Prostate Cancer Therapeutics Drugs Sales (K Pcs) by Sale Channel (2020-2025)
 Table 61. Global Prostate Cancer Therapeutics Drugs Sales (K Pcs) by Sale Channel (2026-2031)
 Table 62. Global Prostate Cancer Therapeutics Drugs Sales Market Share by Sale Channel (2020-2025)
 Table 63. Global Prostate Cancer Therapeutics Drugs Sales Market Share by Sale Channel (2026-2031)
 Table 64. Global Prostate Cancer Therapeutics Drugs Revenue (US$ Million) by Sale Channel (2020-2025)
 Table 65. Global Prostate Cancer Therapeutics Drugs Revenue (US$ Million) by Sale Channel (2026-2031)
 Table 66. Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Sale Channel (2020-2025)
 Table 67. Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Sale Channel (2026-2031)
 Table 68. Global Prostate Cancer Therapeutics Drugs Price (USD/Pcs) by Sale Channel (2020-2025)
 Table 69. Global Prostate Cancer Therapeutics Drugs Price (USD/Pcs) by Sale Channel (2026-2031)
 Table 70. Johnson & Johnson Company Information
 Table 71. Johnson & Johnson Description and Business Overview
 Table 72. Johnson & Johnson Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Johnson & Johnson Prostate Cancer Therapeutics Drugs Product
 Table 74. Johnson & Johnson Recent Developments/Updates
 Table 75. Pfizer, Inc Company Information
 Table 76. Pfizer, Inc Description and Business Overview
 Table 77. Pfizer, Inc Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Pfizer, Inc Prostate Cancer Therapeutics Drugs Product
 Table 79. Pfizer, Inc Recent Developments/Updates
 Table 80. AstraZeneca Company Information
 Table 81. AstraZeneca Description and Business Overview
 Table 82. AstraZeneca Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. AstraZeneca Prostate Cancer Therapeutics Drugs Product
 Table 84. AstraZeneca Recent Developments/Updates
 Table 85. Amgen, Inc Company Information
 Table 86. Amgen, Inc Description and Business Overview
 Table 87. Amgen, Inc Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Amgen, Inc Prostate Cancer Therapeutics Drugs Product
 Table 89. Amgen, Inc Recent Developments/Updates
 Table 90. AbbVie, Inc Company Information
 Table 91. AbbVie, Inc Description and Business Overview
 Table 92. AbbVie, Inc Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. AbbVie, Inc Prostate Cancer Therapeutics Drugs Product
 Table 94. AbbVie, Inc Recent Developments/Updates
 Table 95. Bayer AG Company Information
 Table 96. Bayer AG Description and Business Overview
 Table 97. Bayer AG Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Bayer AG Prostate Cancer Therapeutics Drugs Product
 Table 99. Bayer AG Recent Developments/Updates
 Table 100. Ipsen Group Company Information
 Table 101. Ipsen Group Description and Business Overview
 Table 102. Ipsen Group Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Ipsen Group Prostate Cancer Therapeutics Drugs Product
 Table 104. Ipsen Group Recent Developments/Updates
 Table 105. Sanofi Company Information
 Table 106. Sanofi Description and Business Overview
 Table 107. Sanofi Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Sanofi Prostate Cancer Therapeutics Drugs Product
 Table 109. Sanofi Recent Developments/Updates
 Table 110. Endo Pharmaceuticals Company Information
 Table 111. Endo Pharmaceuticals Description and Business Overview
 Table 112. Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Product
 Table 114. Endo Pharmaceuticals Recent Developments/Updates
 Table 115. Dendreon Corporation Company Information
 Table 116. Dendreon Corporation Description and Business Overview
 Table 117. Dendreon Corporation Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. Dendreon Corporation Prostate Cancer Therapeutics Drugs Product
 Table 119. Dendreon Corporation Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Prostate Cancer Therapeutics Drugs Distributors List
 Table 123. Prostate Cancer Therapeutics Drugs Customers List
 Table 124. Prostate Cancer Therapeutics Drugs Market Trends
 Table 125. Prostate Cancer Therapeutics Drugs Market Drivers
 Table 126. Prostate Cancer Therapeutics Drugs Market Challenges
 Table 127. Prostate Cancer Therapeutics Drugs Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Prostate Cancer Therapeutics Drugs
 Figure 2. Global Prostate Cancer Therapeutics Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Prostate Cancer Therapeutics Drugs Market Share by Type: 2024 & 2031
 Figure 4. Hormone Therapy Product Picture
 Figure 5. Chemotherapy Product Picture
 Figure 6. Biologic Therapy Product Picture
 Figure 7. Targeted Therapy Product Picture
 Figure 8. Other Product Picture
 Figure 9. Global Prostate Cancer Therapeutics Drugs Market Value by Sale Channel (2020-2031) & (US$ Million)
 Figure 10. Global Prostate Cancer Therapeutics Drugs Market Share by Sale Channel: 2024 & 2031
 Figure 11. Hospital Pharmacy
 Figure 12. Retail Pharmacy
 Figure 13. Online Sales
 Figure 14. Other
 Figure 15. Global Prostate Cancer Therapeutics Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Prostate Cancer Therapeutics Drugs Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Prostate Cancer Therapeutics Drugs Sales (2020-2031) & (K Pcs)
 Figure 18. Global Prostate Cancer Therapeutics Drugs Average Price (USD/Pcs) & (2020-2031)
 Figure 19. Prostate Cancer Therapeutics Drugs Report Years Considered
 Figure 20. Prostate Cancer Therapeutics Drugs Sales Share by Manufacturers in 2024
 Figure 21. Global Prostate Cancer Therapeutics Drugs Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Prostate Cancer Therapeutics Drugs Players: Market Share by Revenue in Prostate Cancer Therapeutics Drugs in 2024
 Figure 23. Prostate Cancer Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Prostate Cancer Therapeutics Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Prostate Cancer Therapeutics Drugs Sales Market Share by Country (2020-2031)
 Figure 26. North America Prostate Cancer Therapeutics Drugs Revenue Market Share by Country (2020-2031)
 Figure 27. U.S. Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Prostate Cancer Therapeutics Drugs Sales Market Share by Country (2020-2031)
 Figure 30. Europe Prostate Cancer Therapeutics Drugs Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Prostate Cancer Therapeutics Drugs Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Prostate Cancer Therapeutics Drugs Revenue Market Share by Region (2020-2031)
 Figure 38. China Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. China Taiwan Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Prostate Cancer Therapeutics Drugs Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Prostate Cancer Therapeutics Drugs Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Prostate Cancer Therapeutics Drugs Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Prostate Cancer Therapeutics Drugs Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Prostate Cancer Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Prostate Cancer Therapeutics Drugs by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Prostate Cancer Therapeutics Drugs by Type (2020-2031)
 Figure 59. Global Prostate Cancer Therapeutics Drugs Price (USD/Pcs) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Prostate Cancer Therapeutics Drugs by Sale Channel (2020-2031)
 Figure 61. Global Revenue Market Share of Prostate Cancer Therapeutics Drugs by Sale Channel (2020-2031)
 Figure 62. Global Prostate Cancer Therapeutics Drugs Price (USD/Pcs) by Sale Channel (2020-2031)
 Figure 63. Prostate Cancer Therapeutics Drugs Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Prostate Cancer Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Advanced Prostate Cancer Drug Market Research Report 2025
Global Prostate Cancer Diagnostics and Therapy Market Research Report 2024
Cancer Therapeutics and Biotherapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Prostate Cancer Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Prostate Cancer Diagnosis and Therapy Market Research Report 2024
Lung Cancer Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Precision Cancer Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Castration resistant Prostate Cancer Drugs Market Research Report 2025
Breast Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oncology Anti cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cancers Immunotherapy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Novel Drug Delivery Systems for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tumor Immunotherapy Market
Lung Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Testicular Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Personalizing Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Solid Tumor Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cancer Generics Market
Oral Cancer Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions